Outsourced Pharma Webinars

31. Hear From The Experts: LNPs Driving The Future Of Cell Therapy 12/12/2025

    Explore how lipid nanoparticles are driving breakthroughs in cell therapy, from mRNA-based immune cell engineering to genome editing for CAR T cells and HSPCs from leading experts.

32. Manufacturing Made More Robust And Customer-Centric 12/11/2025

    Discover how regional manufacturing, risk-aware practices, and agile strategies are reshaping supply chains to deliver resilience, transparency, and sustainability in today’s complex global environment.

33. Eliminate Risk From Your Viral Vector Tech Transfers 12/5/2025

    Explore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.

34. Navigating Regulatory Expectations For Injectable Packaging 12/4/2025

    Explore insights on extractables, focusing on how they relate to the revised EU GMP Annex 1, new and evolved expectations under USP <382>, and the use of VHP decontamination in aseptic environments.

35. Critical Path For Gene Therapy: AAV Analytical Lifecycle Considerations 12/2/2025

    Explore considerations for phase-appropriate AAV characterization and release activities from pre-clinical to late-phase products. Review validation challenges and paths for maturation of analytics.

36. Model-Driven Genetic Design And Bioprocess Optimization Across Modalities 12/2/2025

    Traditional biomanufacturing relies too heavily on trial and error. By integrating AI and mechanistic models into early design, developers can overcome productivity limits and accelerate timelines.

37. Raising The Bar In Gene Therapy 12/1/2025

    Learn how a science-driven and digitally structured approach reduced onboarding timelines for gene therapy from 12 months to just 3, setting a new benchmark in technology transfers.

38. Class 3 Atropisomers: Capture Therapeutic Selectivity In Oncology 11/26/2025

    Atropisomers are key to modern small molecule drug development. Learn how advanced manufacturing strategies enable the isolation and scalable production of the most effective single isomer.

39. Extrusion-Based ASD Scale-Up: Performance Through Process Understanding 11/20/2025

    Explore the formulation and manufacturing considerations for amorphous solid dispersions (ASDs), with a focus on hot melt extrusion (HME) as a scalable and cost-effective technology option.

40. Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions 11/20/2025

    Learn how flexible facility design and process innovation are accelerating pDNA manufacturing, as well as key strategies to avoid scale-up pitfalls and meet growing therapeutic demand.